Meeting News

Pyrotinib plus capecitabine improves PFS in HER2-positive breast cancer

July 11, 2019
CHICAGO — The combination of pyrotinib and capecitabine significantly prolonged PFS among patients with HER2-positive metastatic breast cancer…
Meeting NewsVideo

VIDEO: Tumor size, node status, age affect risk for breast cancer mortality

July 10, 2019
CHICAGO — At the ASCO Annual Meeting, Jose Pablo Leone, MD, medical oncologist at Dana-Farber Cancer Institute, spoke with HemOnc Today
Meeting News

Palbociclib plus exemestane improves PFS in premenopausal women with breast cancer

July 9, 2019
CHICAGO — The combination of palbociclib plus exemestane with ovarian suppression significantly prolonged PFS compared with capecitabine in…
Meeting NewsVideo

VIDEO: Eribulin plus pembrolizumab shows no clinical benefit in breast cancer subtype

July 2, 2019
CHICAGO — The addition of pembrolizumab to eribulin demonstrated no significant improvements in terms of PFS, OS or objective response rate…
Meeting News

Capivasertib plus fulvestrant improves outcomes in advanced breast cancer

June 28, 2019
CHICAGO — Adding capivasertib to fulvestrant resulted in markedly longer PFS and overall response rate among patients with endocrine resistant…
Meeting NewsPerspective

Adjuvant chemotherapy demonstrates survival benefit in triple-negative breast cancer subtype

June 24, 2019
CHICAGO — Patients with small, node-negative, triple-negative breast cancer treated with adjuvant chemotherapy experienced improvements in OS…
Meeting NewsVideo

VIDEO: Talazoparib improves PFS in patients with BRCA mutations

June 20, 2019
CHICAGO — At the ASCO Annual Meeting, Jose Pablo Leone, MD, medical oncologist at Dana-Farber Cancer Institute, spoke with HemOnc Today
Meeting NewsVideo

VIDEO: More evidence highlights importance of healthy diet for breast cancer survival

June 17, 2019
CHICAGO — At the ASCO Annual Meeting, Lindsay Peterson, MD, breast medical oncologist at the Washington University School of Medicine, spoke…
Meeting News

Abemaciclib stabilizes brain metastases in breast cancer subtype

June 14, 2019
CHICAGO — Abemaciclib resulted in a clinically meaningful effect on intracranial response rate in patients with brain metastases secondary to…
Meeting NewsVideo

VIDEO: MONALEESA-7 shows ‘exciting’ results in premenopausal breast cancer

June 14, 2019
CHICAGO — The MONALEESA-7 trial demonstrated that adding the CDK4/6 inhibitor ribociclib (Kisqali, Novartis) to endocrine therapy improved OS…